Similarly, ATF5 is involved in cell cycle progression and apoptosis, and has been shown to be over-expressed in CLL with 11q deletions or trisomy 12 versus other cytogenetic sub-groups and associated with shorter time to treatment [42]. Here, ATF5 is linked to B-cell chronic lymphocytic leukemia.